177 related articles for article (PubMed ID: 37311667)
1. Burden of mood symptoms and disorders in implantable cardioverter defibrillator patients: a systematic review and meta-analysis of 39 954 patients.
Ghezzi ES; Sharman RLS; Selvanayagam JB; Psaltis PJ; Sanders P; Astley JM; Knayfati S; Batra V; Keage HAD
Europace; 2023 Jun; 25(6):. PubMed ID: 37311667
[TBL] [Abstract][Full Text] [Related]
2. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease.
Ingles J; Sarina T; Kasparian N; Semsarian C
Int J Cardiol; 2013 Oct; 168(4):3779-84. PubMed ID: 23835269
[TBL] [Abstract][Full Text] [Related]
3. Association of Implantable Cardioverter Defibrillator Therapy with All-Cause Mortality-A Systematic Review and Meta-Analysis.
Qian Z; Zhang Z; Guo J; Wang Y; Hou X; Feng G; Zou J
Pacing Clin Electrophysiol; 2016 Jan; 39(1):81-8. PubMed ID: 26470761
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review.
Magyar-Russell G; Thombs BD; Cai JX; Baveja T; Kuhl EA; Singh PP; Montenegro Braga Barroso M; Arthurs E; Roseman M; Amin N; Marine JE; Ziegelstein RC
J Psychosom Res; 2011 Oct; 71(4):223-31. PubMed ID: 21911099
[TBL] [Abstract][Full Text] [Related]
5. Concerns about implantable cardioverter-defibrillator shocks mediate the relationship between actual shocks and psychological distress.
Thylén I; Moser DK; Strömberg A; Dekker RA; Chung ML
Europace; 2016 Jun; 18(6):828-35. PubMed ID: 26324839
[TBL] [Abstract][Full Text] [Related]
6. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study.
Kamphuis HC; de Leeuw JR; Derksen R; Hauer RN; Winnubst JA
Europace; 2003 Oct; 5(4):381-9. PubMed ID: 14753636
[TBL] [Abstract][Full Text] [Related]
7. Both mental and physical health predicts one year mortality and readmissions in patients with implantable cardioverter defibrillators: findings from the national DenHeart study.
Berg SK; Rasmussen TB; Mols RE; Thorup CB; Borregaard B; Christensen AV; Cromhout PF; Ekholm O; Juel K; Thrysoee L
Eur J Cardiovasc Nurs; 2019 Feb; 18(2):96-105. PubMed ID: 30114937
[TBL] [Abstract][Full Text] [Related]
8. Anxiety and depression as risk factors for ICD shocks and mortality in patients with an implantable cardioverter defibrillator - A systematic review.
Lindekilde N; Skov O; Skovbakke SJ; Johansen JB; Nielsen JC; Pedersen SS
Gen Hosp Psychiatry; 2022; 78():96-107. PubMed ID: 35933929
[TBL] [Abstract][Full Text] [Related]
9. Depressive symptoms in patients after primary and secondary prophylactic ICD implantation.
Ensslin C; Berg J; Hermes-Laufer J; Keller LS; Niederseer D; Pazhenkottil A; von Känel R; Schmied C
Clin Res Cardiol; 2022 Nov; 111(11):1210-1218. PubMed ID: 34779916
[TBL] [Abstract][Full Text] [Related]
10. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
[TBL] [Abstract][Full Text] [Related]
11. Predictors of implantable cardioverter defibrillator shocks during the first year.
Dougherty CM; Hunziker J
J Cardiovasc Nurs; 2009; 24(1):21-8; quiz 29-30. PubMed ID: 19114797
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous versus transvenous implantable cardioverter defibrillators in children and young adults: A meta-analysis.
Vetta G; Parlavecchio A; Magnocavallo M; Valente D; Caminiti R; Polselli M; Vetta F; Cirone D; Cauti FM; Crea P; Rossi P; Chierchia GB; Bianchi S; de Asmundis C; Natale A; Della Rocca DG
Pacing Clin Electrophysiol; 2022 Dec; 45(12):1409-1414. PubMed ID: 36214206
[TBL] [Abstract][Full Text] [Related]
14. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.
Tan VH; Wilton SB; Kuriachan V; Sumner GL; Exner DV
Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):164-70. PubMed ID: 24446023
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database.
MacFadden DR; Crystal E; Krahn AD; Mangat I; Healey JS; Dorian P; Birnie D; Simpson CS; Khaykin Y; Pinter A; Nanthakumar K; Calzavara AJ; Austin PC; Tu JV; Lee DS
Ann Intern Med; 2012 Feb; 156(3):195-203. PubMed ID: 22312139
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
[TBL] [Abstract][Full Text] [Related]
17. Posttraumatic stress 18 months following cardioverter defibrillator implantation: shocks, anxiety, and personality.
Habibović M; van den Broek KC; Alings M; Van der Voort PH; Denollet J
Health Psychol; 2012 Mar; 31(2):186-93. PubMed ID: 21806300
[TBL] [Abstract][Full Text] [Related]
18. Inappropriate shocks in single-chamber and subcutaneous implantable cardioverter-defibrillators: a systematic review and meta-analysis.
Auricchio A; Hudnall JH; Schloss EJ; Sterns LD; Kurita T; Meijer A; Fagan DH; Rogers T
Europace; 2017 Dec; 19(12):1973-1980. PubMed ID: 28340005
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome.
Shinohara T; Abe I; Hirota K; Kondo H; Fukui A; Akioka H; Teshima Y; Yufu K; Nakagawa M; Takahashi N
Heart Vessels; 2021 Feb; 36(2):260-266. PubMed ID: 32833119
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous implantable cardioverter-defibrillator: a systematic review of comparative effectiveness and safety.
Wolf S; Götz G; Wernly B; Wild C
ESC Heart Fail; 2023 Apr; 10(2):808-823. PubMed ID: 36444868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
